Maharashtra CM Eknath Shinde and Devendra Fadnavis Honor Ratan Tata’s Legacy | Top News (10-10-2024)
Stock to watch: Tata Elxsi shares in focus ahead of Q2 results. Here’s what to expect (10-10-2024)
Tata Elxsi’s Q2 results are anticipated to show an 8% growth in net sales to Rs 956 crore and a 21% QoQ jump in net profit to Rs 223 crore. Analysts are keenly watching demand outlook, especially in SDS, transportation, media, and communications verticals.
Gold down Rs 10 at Rs 76,680; silver dips Rs 100, trading at 94,000/kg (10-10-2024)
The price of 22-carat gold also witnessed a decline of Rs 10, with ten grams of the yellow metal selling at Rs 70,290
Tata Group stocks in focus today as former chairman Ratan Tata dies at age 86 (10-10-2024)
Tata Group shares are in focus as former chairman Ratan Tata passed away at age 86. He was a pivotal figure in the company’s history. Tributes pour in from industry leaders and Prime Minister Modi. Shares of Tata Motors, Tata Steel, and Tata Consultancy Services have risen significantly in 2024. Tata companies will begin reporting second-quarter earnings today.
Is it time to invest in FMCG stocks? Sudip Bandyopadhyay answers (10-10-2024)
There will be excitement around this Hyundai IPO and the stocks will get excited. But having said that, if you are talking about medium to long term, it is better to wait and watch and it is much better to play this space through ancillaries because we have fantastic auto ancillary companies and some of these auto ancillary companies are global in nature.
Retail credit boom creating balance sheet risks: Shweta Daptardar (10-10-2024)
There will be recalibration even on the risk pricing rates front as well. Perhaps we might see some review in guidelines coming from RBI in near future, say in terms of how the risk pricing, credit risk management should happen.
Overweight on pharma as a quarterly trade; NBFCs to outperform banks long term: Dipan Mehta (10-10-2024)
Dipan Mehta highlights potential trends in various market sectors. He is optimistic about pharma’s short-term growth and believes NBFCs will outperform banks in the coming years. However, he remains cautious about metals and emphasizes the need for careful stock selection. He suggests focusing on sectors with significant corrections and promising outlooks.